- Travel tech firm Navan eyes $6.45 billion valuation in US IPO Reuters
- Navan sets price range for IPO, expects market cap of up to $6.5 billion CNBC
- Navan pushes ahead with IPO, eyes rare SEC workaround amid shutdown ION Analytics
- NAVN IPO News – Corporate travel software provider Navan sets terms for $923 million IPO renaissancecapital.com
- Travel tech firm Navan aims to raise up to $960 million in US IPO Yahoo Finance
Category: 3. Business
-
Travel tech firm Navan eyes $6.45 billion valuation in US IPO – Reuters
-

Inheritance Planning: Intergenerational Wealth Transfer
Michelle Weaver: Welcome to Thoughts on the Market. I’m Michelle Weaver, Morgan Stanley’s U.S. Thematic and Equity Strategist.
Today, a powerful force reshaping the financial lives of millions of Americans: inheritance.
It’s Friday, October 10th at 10am in New York.
Americans are living longer and they’re passing on their wealth later. Longevity is one of Morgan Stanley Research’s four key themes, and this is an interesting element of longevity. As baby boomers age, they’re expected to transfer their wealth to Gen X, millennials and Gen Z to the tune of tens or even hundreds of trillions of U.S. dollars.
Estimates vary widely, but the amounts are unprecedented. And so, inheritance isn’t just a family milestone. It’s becoming an important cornerstone of financial planning and longevity. And understanding who’s receiving, expecting, and using their inheritances is key to forecasting how Americans save, spend, and invest.
According to our latest, AlphaWise survey, 17 percent of U.S. consumers have received an inheritance, and another 14 percent expect to receive one in the future. Younger Americans are especially optimistic. Their expectations split evenly between those anticipating an inheritance within the next 10 years and those expecting it further out.
But here’s the kicker; income plays a huge role. Only 17 percent of lower income consumers report receiving or expecting an inheritance, but that number jumps to 43 percent among higher income households highlighting a clear wealth divide.
What about the size of the inheritance? In our survey, those who received or expect to receive an inheritance fall broadly into three categories. About half reported amounts under $100,000 dollars. For about a third, that amount rose to under $500,000. And then meanwhile, 10 per cent reported an inheritance of half a million dollars or more.
Younger consumers tend to report smaller amounts, while inheritance size rises with income. One important thing to remember about our survey though, is it looks more at the average person. We are missing some of those very high net worth demographics in there where I would expect inheritance to rise much higher than half a million.
And so, when we think about this, how will recipients use this wealth? That’s a really important question. The majority, about 60 percent, say they have or will put their inheritance towards savings, retirement, or investments. About a third say they’ll use it for housing or paying down debt. Day-to-day consumption, travel, education and even starting a business or giving to charity also featured in the survey responses – but to a lesser extent.
The financial impact of inheritance is significant: 46 percent of recipients say it makes them feel more financially secure; 40 percent cite improvements in savings and; 22 percent associate it with increased spending. Some even report retiring earlier or lightening their workloads.
Inheritance trends are shaping consumer behavior and have the power to influence spending patterns across industries. To sum it up, inheritance isn’t just a family matter, it’s a market mover.
Thanks for listening. If you enjoy the show, please leave us a review wherever you listen, and share Thoughts on the Market with a friend or colleague today.
Continue Reading
-
Access Denied
Access Denied
You don’t have permission to access “http://www.spglobal.com/market-intelligence/en/news-insights/research/2025/10/visible-alpha-breakdown-of-us-banks-third-quarter-earnings-expectations” on this server.
Reference #18.daa0d517.1760144947.1fdf874c
https://errors.edgesuite.net/18.daa0d517.1760144947.1fdf874c
Continue Reading
-

82% Freedom from VT/VF Recurrence and 98% Reduction in Burden
Findings presented at the International VT Symposium and published simultaneously in Circulation.
CARDIFF-BY-THE-SEA, Calif. and PHILADELPHIA, Oct. 10, 2025 /PRNewswire/ — Field Medical, Inc. today announced that Circulation has published six-month outcomes from the Ventricular Catheter Ablation Study (VCAS), the first-in-human evaluation of its FieldForce™ Ablation System for ventricular tachycardia (VT). Results were also presented as a late-breaking trial at the 20th Annual International Symposium on Ventricular Arrhythmias (VT Symposium).
The FieldForce™ Ablation System by Field Medical: This next-generation PFA system is designed for transmural lesion creation, offering a novel approach to VT ablation.
Results at Six Months
VCAS is a prospective, multicenter feasibility trial evaluating the safety and performance of the FieldForce Ablation System in patients with VT. Unlike conventional approaches, the system delivers a proprietary high-voltage, short-pulse waveform designed to penetrate dense scar tissue while minimizing thermal injury.Key Findings:
- 82% freedom from recurrent VT/VF or ICD therapy
- 98% reduction in VT/VF burden (episodes)
- 11.5% had a primary safety event with 0 therapy-related complications
“While this remains an initial feasibility study, the six-month outcomes are highly encouraging. Achieving 82% freedom from recurrence and a 98% reduction in arrhythmia burden with a nonthermal, tissue-selective energy is a meaningful result in VT therapy. Importantly, this is the first time we’ve seen evidence that PFA can reach deep, transmural scar tissue in the ventricle, a long-standing challenge with existing energy sources,” said Vivek Reddy, M.D., co-principal investigator, lead author, and electrophysiologist at Mount Sinai, New York. “These findings give me cautious optimism that with continued refinement, this approach could represent an important advance in the treatment of scar-related VT.”
With U.S. Food and Drug Administration’s (FDA) Breakthrough Device designation and acceptance into the FDA Total Product Life Cycle (TAP) Pilot Program, Field Medical is advancing this program toward a pivotal trial and a rigorous evaluation of high-voltage focal PFA in VT.
“It is rare for initial feasibility data to be published in Circulation, and this underscores both the rigor and the significance of the work,” said Steven Mickelsen, M.D., founder and chief technology officer of Field Medical. “Our mission has always been to unite scientific credibility with innovation. These findings mark an important milestone as we continue to evaluate pulsed field ablation for its potential to improve outcomes for patients with ventricular arrhythmias.”
Looking ahead, the company is evaluating additional applications of its FieldForce Ablation System beyond VT and expects to present initial feasibility findings in atrial fibrillation (AF) at a major scientific meeting in early 2026.
About FieldForce™ Ablation System
The FieldForce Ablation System features a single-point contact force PFA catheter with an innovative design utilizing proprietary FieldBending™ technology to deliver targeted, brief, high-intensity electric fields. This next-generation PFA technology was designed to deliver both precise targeted lesions and large volume transmural lesions in the ventricle.About Field Medical®, Inc.
Founded in 2022, Field Medical is a clinical-stage medical technology company committed to advancing pulsed field ablation (PFA) solutions for complex cardiac arrhythmias. Its FieldForce Ablation System integrates a focal catheter design with proprietary FieldBending energy designed to safely deliver efficient, precise ablation with the goal of improving outcomes in ventricular and atrial arrhythmia treatment. In 2024, Field Medical earned Breakthrough Device Designation and gained entry into the FDA TAP Pilot Program for its ventricular tachycardia indication.For more information, visit www.fieldmedicalinc.com and follow us on LinkedInX, and YouTube.
The FieldForce™ Ablation System is an investigational device and is limited by federal (or United States) law to investigational use.
Source:
Reddy VY, et al. High-Voltage Focal Pulsed Field Ablation to Treat Scar-Related Ventricular Tachycardia: The First-in-Human VCAS Trial. Circulation. Published online ahead of print October 10, 2025. doi:10.1161/CIRCULATIONAHA.125.077025CONTACT: Holly Windler, 619.929.1275, [email protected]
Photo – https://mma.prnewswire.com/media/2792975/Field_Medical_FieldForce__Ablation_System_Next_generation_PFA.jpg
Logo – https://mma.prnewswire.com/media/2574173/Field_Medical_Logo_Block_WhiteOnBlack_Logo.jpgContinue Reading
-
Johnson & Johnson recommends shareholders reject “mini-tender” offer by Tutanota
New Brunswick, New Jersey (October 10, 2025) – Johnson & Johnson (NYSE: JNJ) today announced that it has received notice of an unsolicited mini-tender offer by Tutanota LLC, a limited liability company established pursuant to the laws of the Island of Nevis to purchase up to 500,000 shares of Johnson & Johnson common stock at a price of $145.00 per share in cash. Tutanota’s offer price of $145.00 per share was well below the closing price of Johnson & Johnson common stock on September 26, 2025, the last full trading day prior to the date of the offer. Moreover, the offer is conditioned on, among other things, the closing price per share of Johnson & Johnson common stock exceeding $145.00 on the last trading day before the offer expires. This means that unless this condition is waived by Tutanota, Johnson & Johnson shareholders who tender their shares in the offer will receive a below-market price. Tutanota further states in its offering documents that it expects to extend the offer for successive periods of 45 to 180 days until the market price of the shares exceeds the offer price. The offer is for approximately 0.0207% of the shares of Johnson & Johnson common stock outstanding as of the September 29, 2025 offer date.
Johnson & Johnson is not associated in any way with Tutanota LLC or its unsolicited mini-tender offer and recommends that shareholders do not tender their shares in response to Tutanota’s offer because the offer is at a price below the current market price for Johnson & Johnson’s shares and subject to numerous conditions.
Tutanota has made many similar mini-tender offers for shares of other companies. Mini-tender offers seek to acquire less than 5 percent of a company’s shares outstanding, thereby avoiding many disclosure and procedural requirements of the U.S. Securities and Exchange Commission (SEC) that would otherwise apply. As a result, mini-tender offers do not provide investors with the same level of protections as provided for larger tender offers under U.S. securities laws.
The SEC has cautioned investors that some bidders making mini-tender offers at below-market prices are “hoping that they will catch investors off guard if the investors do not compare the offer price to the current market price.” More on the SEC’s guidance to investors on mini-tender offers is available at
https://www.sec.gov/rules-regulations/2000/07/commission-guidance-mini-tender-offers-limited-partnership-tender-offers.Johnson & Johnson urges investors to obtain current market quotations for their shares, to consult with their broker or financial advisor and to exercise caution with respect to Tutanota’s offer. Johnson & Johnson recommends that shareholders who have not responded to Tutanota’s offer take no action. The offer is currently scheduled to expire at 5:00 p.m., New York City time, on Wednesday, October 29, 2025, unless extended or earlier terminated.
Johnson & Johnson encourages brokers and dealers, as well as other market participants, to review the SEC’s letter regarding broker-dealer mini-tender offer dissemination and disclosure at
www.sec.gov/divisions/marketreg/minitenders/sia072401.htm.About Johnson & Johnson
At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more at
www.jnj.com.
Continue Reading
-

Amazon (AMZN)’s Upcoming “Big Event” Could Matter, Says Jim Cramer
We recently published 16 Stocks Jim Cramer Mentioned In An Episode Where He Said OpenAI Could Beat All Big Tech Giants. Amazon.com, Inc. (NASDAQ:AMZN) is one of the stocks Jim Cramer recently discussed.
Cramer has discussed Amazon.com, Inc. (NASDAQ:AMZN) several times in 2025. Recently, he called the firm an “underrated AI story,” after discussing its cloud computing business and in-house chips on several occasions. While Cramer was initially skeptical of Amazon.com, Inc. (NASDAQ:AMZN) relying on the in-house chips instead of buying NVIDIA’s products, he changed his mind later on and pointed out that the shares had dipped after the firm’s latest earnings report due to the AI chip concerns. Cramer also recently commented that he couldn’t “remember” what was wrong with Amazon.com, Inc. (NASDAQ:AMZN), and this time he discussed the overall sentiment surrounding the firm:
Amazon (AMZN)’s Upcoming “Big Event” Could Matter, Says Jim Cramer christian-wiediger-rymh7EZPqRs-unsplash
“Well we have a big Amazon event coming up. I think that could matter. A lot of people feel that Amazon, I’m never going to say they lost their way, they’re too smart. But that Amazon, has been, ho-hum, and I don’t think Andy Jassy feels it’s been ho-hum. But your record is your record. And, right now, he’s got the L for the year, not the W.”
While we acknowledge the potential of AMZN as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock.
READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.
Disclosure: None. This article is originally published at Insider Monkey.
Continue Reading
-

WIRED Roundup: Are We In An AI Bubble? – WIRED
- WIRED Roundup: Are We In An AI Bubble? WIRED
- Jamie Dimon is worried about a stock market correction CNN
- ‘It’s going to be really bad’: Fears over AI bubble bursting grow in Silicon Valley BBC
- AMD Inks Chip Deal With OpenAI That Triggers Explosive Rally Bloomberg.com
- Is there an AI bubble? Financial institutions sound a warning AP News
Continue Reading
-
Access Denied
Access Denied
You don’t have permission to access “http://www.spglobal.com/market-intelligence/en/news-insights/articles/2025/10/dc-capital-acquires-agi-harkness-snaps-up-premier-fence-93737367” on this server.
Reference #18.daa0d517.1760170032.231d58b6
https://errors.edgesuite.net/18.daa0d517.1760170032.231d58b6
Continue Reading
-

Samsung Expands Home Appliance Remote Management (HRM) Service Globally to Enhance Customer Experience – Samsung Newsroom Canada
Now available in 122 countries and 17 languages, HRM delivers faster, more seamless customer support across borders
Samsung Electronics Co., Ltd is expanding it Home Appliances Remote Management (HRM) service globally, enhancing the remote diagnostic and troubleshooting experience for smart appliances users around the world. The service is now active across 122 countries including Canada with support for 17 languages, enabling seamless support for a wide global customer base.
HRM is a service that connects SmartThings-connected appliances to Samsung’s service network, maintaining a continuous record of device conditions and enabling real-time monitoring through the service center.
“Samsung’s HRM service exemplifies our commitment to proactive, smart customer care,” said Miyoung Yoo, EVP and Head of Global Customer Satisfaction Team, Digital Appliance (DA) Business at Samsung Electronics. “Thanks to the combination of seamless connectivity and real-time insights, this service helps to reduce complexity for our customers, ultimately enhancing their overall satisfaction.”
Enhancing Service for Screen Appliances
In line with the expansion of screen-equipped appliances like Bespoke refrigerators and washing machines, Samsung has also introduced a screen-sharing feature to enhance diagnostic capabilities. For various screens of 7”, 9”, and Family Hubs, its users can share their device screens in real time with service centre advisors, allowing diagnosis of display-related issues, app malfunctions or multimedia playback problems.
Immediate Solutions and Reduced Service Visits through Remote Assistance
Samsung’s HRM service improves a new avenue for customer care by enabling real-time remote solutions for simple product issues that previously required in-home technician visits. For instance, for a customer that reported that the washing machine’s buttons were not responding, the advisor was able to diagnose through the HRM system that the Child Lock setting was active. With simple guidance on how to disable the setting, the problem was solved instantly without a technician’s visit. In another case where a customer reported condensation on the refrigerator door, with user consent, the advisor was able to remotely turn on the internal heater, which effectively eliminated the moisture.
In cases when an on-site visit is ultimately necessary, HRM improves the experience by allowing technicians to review detailed diagnostic data in advance. They are able to arrive at the site prepared, potentially reducing repeat visits and repair times.
Growing Adoption and User Satisfaction
With the continued expansion of customer support solutions like HRM, Samsung is realizing convenient and efficient ways to care for home appliances – reducing downtime, enhancing the user experience and setting new standards for global service. As HRM reaches more countries, languages and product categories, Samsung remains committed to delivering smarter, more connected care for the homes of the future.
HRM is supported on SmartThings-enabled models released after 2019. Must download the SmartThings app available on Android and iOS devices. A Wi-Fi connection and a Samsung account are required.
In Korea, HRM supports refrigerators, washing machines, dryers, air conditioners, vacuum cleaners, and dishwashers. In Canada, HRM supports refrigerators and washing machines.
Continue Reading
-

Trump, Nvidia, and Apple Just Flipped the Script
This article first appeared on GuruFocus.
Intel’s (NASDAQ:INTC) comeback could be one of the most surprising corporate turnarounds this year. After President Donald Trump publicly called for CEO Lip-Bu Tan’s resignation earlier this summer, few expected the story to flip this fast. But it did. Since the White House signaled plans to take a 10% stake in Intel, the company’s shares have climbed more than 50%, marking one of its strongest rallies in years. The political backing ignited a string of high-profile investmentsSoftBank committed $2 billion, followed by Nvidia’s (NASDAQ:NVDA) $5 billion partnership deal to co-develop chips for PCs and data centers. Reports also suggest Apple has explored a potential collaboration, though talks remain preliminary.
Beyond the headlines, Intel is quietly rebuilding the core of its business. The company confirmed that its next-generation Panther Lake chips, built on its 18A manufacturing process, are now in full production and slated for laptops early next year. This technology marks Intel’s long-awaited return to producing its most advanced chips in-house after years of outsourcing to TSMC. Intel’s management views the 18A process as a critical testone that could finally position its foundry unit to win new contracts from major designers like Nvidia and Apple (NASDAQ:AAPL), provided the performance holds up under industry scrutiny.
The next phase, however, may hinge on execution rather than momentum. Nvidia said it will monitor Intel’s progress before committing further, while Apple’s potential involvement could start with simpler products such as Apple TV chips. Still, Intel’s strengthened relationship with Washington could prove strategically valuable, offering companies a politically favored path to build in America without constructing their own facilities. Investors seem to sense that Intel’s reset is gaining tractionbut transforming optimism into long-term customer demand will be the real test of whether Lip-Bu Tan’s turnaround plan can endure.
Continue Reading